KIDS vs. SILK, FNA, ATRI, TMCI, AORT, SIBN, ATRC, EMBC, MDXG, and IRMD
Should you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include Silk Road Medical (SILK), Paragon 28 (FNA), Atrion (ATRI), Treace Medical Concepts (TMCI), Artivion (AORT), SI-BONE (SIBN), AtriCure (ATRC), Embecta (EMBC), MiMedx Group (MDXG), and Iradimed (IRMD). These companies are all part of the "surgical & medical instruments" industry.
OrthoPediatrics (NASDAQ:KIDS) and Silk Road Medical (NASDAQ:SILK) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, community ranking, valuation, media sentiment, profitability and risk.
69.1% of OrthoPediatrics shares are held by institutional investors. 31.8% of OrthoPediatrics shares are held by insiders. Comparatively, 6.7% of Silk Road Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
OrthoPediatrics currently has a consensus price target of $45.50, indicating a potential upside of 43.13%. Silk Road Medical has a consensus price target of $22.55, indicating a potential upside of 0.43%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, research analysts plainly believe OrthoPediatrics is more favorable than Silk Road Medical.
OrthoPediatrics has higher earnings, but lower revenue than Silk Road Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Silk Road Medical, indicating that it is currently the more affordable of the two stocks.
OrthoPediatrics has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, Silk Road Medical has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500.
OrthoPediatrics received 216 more outperform votes than Silk Road Medical when rated by MarketBeat users. Likewise, 64.56% of users gave OrthoPediatrics an outperform vote while only 50.56% of users gave Silk Road Medical an outperform vote.
OrthoPediatrics has a net margin of -13.58% compared to Silk Road Medical's net margin of -29.02%. OrthoPediatrics' return on equity of -5.12% beat Silk Road Medical's return on equity.
In the previous week, OrthoPediatrics had 3 more articles in the media than Silk Road Medical. MarketBeat recorded 5 mentions for OrthoPediatrics and 2 mentions for Silk Road Medical. Silk Road Medical's average media sentiment score of 1.87 beat OrthoPediatrics' score of 0.18 indicating that Silk Road Medical is being referred to more favorably in the news media.
Summary
OrthoPediatrics beats Silk Road Medical on 13 of the 18 factors compared between the two stocks.
Get OrthoPediatrics News Delivered to You Automatically
Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OrthoPediatrics Competitors List
Related Companies and Tools
